M. Hudock

发表

Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome

Leming Shi, Lun Yang, Kejian Wang, 2010, PloS one.

Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.

Ting-Kai Chang, Kilannin Krysiak, Mitsuo Ochi, 2009, Journal of the American Chemical Society.

Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes.

E. Oldfield, M. Hudock, Yongcheng Song, 2006, Journal of the American Chemical Society.

Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.

E. Oldfield, M. Hudock, K. Puan, 2006, Journal of medicinal chemistry.

Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.

Eric Oldfield, E. Oldfield, V. Yardley, 2006, Journal of medicinal chemistry.

Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases

E. Oldfield, M. Hudock, A. H. Wang, 2007, Proceedings of the National Academy of Sciences.

Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.

Po-Huang Liang, Rong Cao, Eric Oldfield, 2008, Journal of medicinal chemistry.

Diterpene cyclases and the nature of the isoprene fold

E. Oldfield, M. Hudock, R. Peters, 2010, Proteins.

Activity of sulfonium bisphosphonates on tumor cell lines.

E. Oldfield, M. Hudock, Kilannin Krysiak, 2007, Journal of medicinal chemistry.

[2-(3-Fluoropyridinium-1-yl)-1-hydroxy-1-phosphonoethyl]phosphonate

E. Oldfield, M. Hudock, R. Cao, 2006 .

[2-(Dimethylsulfonio)-1-hydroxy-1-phosphonoethyl]phosphonate monohydrate

E. Oldfield, M. Hudock, R. Cao, 2006 .

1-Hydroxy-1-phosphono-2-(trimethylarsonium-1-yl)ethanephosphonate monohydrate

E. Oldfield, M. Hudock, R. Cao, 2006 .